custom search
REVERSED
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2875 Ex Parte Hong et al 11511423 - (D) NAGUMO 103 MORGAN LEWIS & BOCKIUS LLP (WA) DZIERZYNSKI, EVAN P
AFFIRMED
Tech Center 1700 Chemical & Materials Engineering
1711 Ex Parte Wochner et al 12674299 - (D) ROESEL 103 BROOKS KUSHMAN P.C. DUNLAP, CAITLIN NOELLE DENNI
The fact that Wochner also discloses many other possible combinations of acids does not support nonobviousness. Merck & Co., Inc. v. Biocraft Labs., Inc., 874 F.2d 804, 807 (Fed. Cir. 1989) (that reference “discloses a multitude of effective combinations does not render any particular formulation less obvious,” especially where “the claimed composition is used for the identical purpose taught by the prior art”); In re Susi, 440 F.2d 442, 445 (CCPA 1971) (obviousness rejection affirmed where the disclosure of the prior art was “huge, but it undeniably include[d] at least some of the compounds recited in appellant’s generic claims and [was] of a class of chemicals to be used for the same purpose as appellant’s additives”).
Merck & Co. v. Biocraft Laboratories, 874 F.2d 804, 10 USPQ2d 1843 (Fed. Cir. 1989) 716.02(a) , 2123 , 2144.05 , 2144.08
Susi, In re, 440 F.2d 442, 169 USPQ 423 (CCPA 1971) 2123 , 2144.08
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2859 Ex Parte Harris 12552238 - (D) GARRIS 103 Law Office of Scott C Harris, Inc RAMADAN, RAMY O
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3769 Ex Parte Kilborn et al 11386038 - (D) FREDMAN 103 37 C.F.R. § 41.50(b) 103 Nellcor Puritan Bennett LLC SORIANO, BOBBY GILES
SEARCH
PTAB.US: Decisions of PTAB Patent Trial and Appeal Board